Catalent Continues to Make Investments, an Industrial Info Market Brief

Industrial Info is tracking eight operational plants across Europe (see map below) owned by Catalent Pharma Solutions, a provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. Globally, Industrial Info is tracking more than $300 million worth of project activity by Catalent.

Catalent recently announced plans to invest $27 million to commercialize Zydis® Ultra, an oral disintegrating tablet.